RDY (Dr. Reddy's Laboratories Limited) שווי מצרפי של נכסים

Dr. Reddy's Laboratories is implementing green chemistry to reduce production toxicity while adhering to strict ESG standards. Due to drug affordability and the resolution of regulatory claims, the brand maintains high authority among medical professionals. The business relies on the expansion of biosimilars and oncology drugs, leveraging low-cost development in India. The market value dynamics of the asset on GURU.Markets show that total assets amount to 6044.82.

Total assets reflect the aggregate resources of the company, formed through equity and borrowed funds. This metric is calculated inversely via return on assets (ROA), which allows for the daily tracking of resource dynamics rather than relying solely on financial reports. Analyzing consolidated assets helps identify risks of capital base degradation. For Dr. Reddy's Laboratories (RDY), the growth of this indicator depends critically on biosimilar investments and FDA approvals.